Three-dimensional illustration of pink and blue virus particles

Protecting Trial Integrity- Independent Interim Analysis and IDMC Support in a Phase II Breast Cancer Study

1 minute read

Published: October 29th, 2026

Interim analyses and safety reviews play a critical role in clinical trial oversight, providing decision-makers with timely insights while safeguarding study integrity. 

In this Phase II breast cancer study, we supported three safety review committees and a formal interim analysis, delivering validated statistical outputs, independent statistical oversight, and secure management of blinded and unblinded data. 

By combining technical expertise with experienced IDMC leadership, the team helped ensure confident, evidence-based decision-making throughout the study. 

Download the full case study to see how we support high-quality interim analyses, safety reviews, and independent data monitoring activities across oncology development programs.

Related articles

From Rescue Study to Strategic Partnership: Accelerating Regulatory Submission Through Reliable Statistical Delivery

From Rescue Study to Strategic Partnership: Accelerating Regulatory Submission Through Reliable Statistical Delivery

November 16th, 2026 1 minute read

When clinical development programs face quality concerns, resource shortages, or submission risks, sponsors need a pa...

Turning a Failed Bioequivalence Study into a Successful Regulatory Outcome 

Turning a Failed Bioequivalence Study into a Successful Regulatory Outcome 

November 16th, 2026 1 minute read

When a bioequivalence study fails to meet regulatory criteria, understanding why is critical for successful developme...

Independent DMC Support and Interim Analysis for an ALS Clinical Trial 

Independent DMC Support and Interim Analysis for an ALS Clinical Trial 

November 16th, 2026 1 minute read

Data Monitoring Committees play a vital role in safeguarding patient safety and supporting informed decision-making t...